Global NewsNews

Fujifilm, Lunit launch AI-powered product for chest X-ray in Japan

Findings detected by the AI software are shown in colour as a heatmap display, with each score included

Fujifilm Corporation announced its AI-powered product for analyzing chest X-ray ‘CXR-AID’ will be commercially available across Japan. CXR-AID is designed to better detect major abnormal findings such as chest nodule, consolidation, and pneumothorax from chest X-ray images. Findings detected by the AI software are shown in colour as a heatmap display, with each score included. Through this solution, doctors and medical professionals can reduce missed cases and effectively diagnose chest diseases from chest X-ray.

The PMDA approved AI-powered software is developed with the core AI technology of Lunit, the company’s solid partner since 2018. The software is provided with Fujifilm’s PACS system(SYNAPSE) and is to be distributed across hospitals and medical institutions of Japan for more efficient diagnosis. A leading medical AI company, Lunit provides deep-learning-based AI technology called ‘Lunit INSIGHT CXR‘ that analyses chest X-rays.

With Lunit AI connected to Fujifilm’s PACS system and X-ray devices, the AI products are distributed across its global customers and networks. The company has also invested in Lunit as a strategic investor.

Based on this market needs, the two companies are expanding their scope of collaboration. Lunit AI is also applied in Fujifilm’s mobile X-ray device (FDR nano) and portable X-ray devices (FDR Xair), General X-ray device (FDR Smart X), and is in use in clinical settings to detect COVID-19 symptoms and tuberculosis in regions where there are a limited number of doctors. The products are installed worldwide including in the UK, Thailand, Vietnam, Turkey, Middle East and Africa. Recently, Lunit’s AI solution for breast cancer detection, Lunit INSIGHT MMG, has been implemented in NURA, Fujifilm’s AI-based healthcare centre in India.

“We strongly believe that sooner or later AI will become the new standard of care, and AI will be used everywhere as a must-use product,” added Suh. “Not only will it be used as a tool to make the workflow more efficient, but it will ensure better diagnosis and healthier life for patients. We are glad to make this happen with Fujifilm, and will accelerate our expansion with its global network.”

 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close